All hopes seem to be lost for Lundbeck with Alzheimer’s candidate idalopirdine, as the last two phase III studies have been as disappointing as the first and the group has decided not to pursue a regulatory path for the drug.
BY ELIZABETH MØNSTED JOHANSEN Offentliggjort 08.02.17 kl. 10:52
Log ind for at læse artikler
Velkommen til MedWatch. En del af vores indhold er eksklusivt og forbeholdt vores brugere.
The average monthly salary in the private pharmaceutical industry in Denmark is DKK 57,109. Make the jump to find out which company pays the highest wages and learn how much the rest of the industry pays as well.
The world’s largest hearing device dealer, Amplifon, expresses concern over the entry into the retail market of manufacturers such as William Demant. GN Resound, on the other hand, receives praise and is expected to form even closer ties to its Italian collaborator.
Novo Seeds has teamed up with innovation incubator Borean to inject millions in a “very exciting project”, which the investment company was made aware of by an executive at ALK through a third company. Moreover, they have attracted a foreign profile to the role as chairman.
Leo Pharma has won a positive CHMP-recommendation of the biological drug brodalumab – an important milestone in the company’s gamble on biologics “This shows that we take the biological field seriously,” says its R&D chief.
GlaxoSmithKline trækker endnu engang flere partier af en udbredt type inhalator brugt i astma- og KOL-behandling tilbage fra det amerikanske marked. Tilbagekaldelsen er nu samlet set på mere end 1,1 millioner enheder.
Forbrugerne vil hellere have foretaget en hjerteoperation af en robot end at betro en robot opgaven at åbne en opsparingskonto, viser en undersøgelse foretaget af den britiske storbank HSBC. Det skriver Finextra.